News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story

Immunoscape studying immune response to Covid-19

By JLABS

Read full story

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story